Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience

被引:9
|
作者
Mohan, Meera [1 ]
Rein, Lisa E. [1 ]
Thalambedu, Nishanth [2 ]
Ogunsesan, Yetunde [2 ]
Hussain, Munawwar [2 ]
Sethi, Jaskirat [2 ]
Khan, Fatima [2 ]
Gundarlapalli, Sravani [2 ]
Yarlagadda, Lakshmi [2 ]
Dhakal, Binod [1 ]
Price, Mary [3 ]
Shirey, Megan [3 ]
Warner, Davie [3 ]
Thanendrarajan, Sharmilan [2 ]
Janz, Siegfried [1 ]
Radhakrishnan, Sabarinath Venniyil [1 ]
Al Hadidi, Samer [2 ]
Szabo, Aniko [1 ]
D'Souza, Anita [1 ]
Zangari, Maurizio [2 ]
van Rhee, Frits [2 ]
Chhabra, Saurabh [1 ]
Schinke, Carolina [2 ]
机构
[1] Med Coll Wisconsin, Froedtert Clin Canc Ctr, Div Hematol Oncol, Milwaukee, WI 53226 USA
[2] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Div Hematol Oncol, Myeloma Ctr, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Jones Eye Inst, Dept Ophthalmol, Little Rock, AR 72205 USA
基金
美国国家卫生研究院;
关键词
MULTIPLE-MYELOMA;
D O I
10.1002/ajh.26728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E451 / E453
页数:3
相关论文
共 50 条
  • [1] Belantamab Mafodotin in Relapse/Refractory AL Amyloidosis- Real-Life Multi-Center Experience
    Lebel, Eyal
    Vainstein, Vladimir
    Milani, Paolo
    Palladini, Giovanni
    Shragai, Tamir
    Lavi, Noa
    Magen, Hila
    Miri, Assayag
    Mazza, Irit Avivi
    Gatt, Moshe E.
    BLOOD, 2023, 142
  • [2] Corneal epithelial toxicity induced by belantamab mafodotin
    Patel, Savan V.
    Joshi, Nisarg
    Thareja, Tarika
    Jhanji, Vishal
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (09): : 1113 - 1115
  • [3] A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH BELANTAMAB MAFODOTIN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Condorelli, A.
    Garibaldi, B.
    Gagliano, C.
    Romano, A.
    Ragusa, M.
    Del Fabro, V.
    Parrinello, N. L.
    Longo, A.
    Cosentino, S.
    Di Raimondo, F.
    Conticello, C.
    HAEMATOLOGICA, 2021, 106 (10) : 169 - 169
  • [4] Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences
    More, Sonia
    Offidani, Massimo
    Corvatta, Laura
    Petrucci, Maria Teresa
    Fazio, Francesca
    CANCERS, 2023, 15 (11)
  • [5] Corneal toxicity associated with belantamab mafodotin: a case series
    Denisova, Ksenia
    Sica, Roberto Alejandro
    Kang, Joann
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [6] “Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience
    I. Vaxman
    J. Abeykoon
    A. Dispenzieri
    S. K. Kumar
    F. Buadi
    M. Q. Lacy
    D. Dingli
    Y. Hwa
    A. Fonder
    M. Hobbs
    C. Reeder
    T. Sher
    S. Hayman
    T. Kourelis
    R. Warsame
    E. Muchtar
    N. Leung
    R. Go
    W. Gonsalves
    M. Siddiqui
    R. A. Kyle
    S. V. Rajkumar
    McCullough Kristen
    P. Kapoor
    M. A. Gertz
    Blood Cancer Journal, 11
  • [7] "Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience
    Vaxman, I
    Abeykoon, J.
    Dispenzieri, A.
    Kumar, S. K.
    Buadi, F.
    Lacy, M. Q.
    Dingli, D.
    Hwa, Y.
    Fonder, A.
    Hobbs, M.
    Reeder, C.
    Sher, T.
    Hayman, S.
    Kourelis, T.
    Warsame, R.
    Muchtar, E.
    Leung, N.
    Go, R.
    Gonsalves, W.
    Siddiqui, M.
    Kyle, R. A.
    Rajkumar, S., V
    Kristen, McCullough
    Kapoor, P.
    Gertz, M. A.
    BLOOD CANCER JOURNAL, 2021, 11 (12)
  • [8] "Real-Life" Data of the Efficacy and Safety of Belantamab Mafodotin in Relapsed Multiple Myeloma- the Mayo Clinic Experience
    Vaxman, Iuliana
    Abeykoon, Jithma P.
    Dispenzieri, Angela
    Kumar, Shaji
    Buadi, Francis K.
    Lacy, Martha Q.
    Dingli, David
    Hwa, Yi Lisa
    Fonder, Amie
    Hobbs, Miriam A.
    Reeder, Craig B.
    Sher, Taimur
    Hayman, Suzanne R.
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Muchtar, Eli
    Leung, Nelson
    Gonsalves, Wilson I.
    Siddiqui, Mustaqeem A.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    McCullough, Kirsten
    Kapoor, Prashant
    Gertz, Morie A.
    BLOOD, 2021, 138
  • [9] Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience
    Iula, Rossella
    De Novellis, Danilo
    Trastulli, Fabio
    Della Pepa, Roberta
    Fontana, Raffaele
    Carobene, Angela
    Di Perna, Maria
    D'Ambrosio, Alessandro
    Romano, Martina
    Leone, Aldo
    De Fazio, Laura
    Fiumarella, Alfonso
    Gaeta, Giuseppe
    Marafioti, Violetta
    Barbato, Serafina
    Palmieri, Salvatore
    Rocco, Stefano
    Serio, Bianca
    Califano, Catello
    Pane, Fabrizio
    Ferrara, Felicetto
    Giudice, Valentina
    Selleri, Carmine
    Catalano, Lucio
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Corneal Toxicity Associated With Belantamab Mafodotin Is Not Restricted to the Epithelium: Neuropathy Studied With Confocal Microscopy
    Aschauer, Julia
    Donner, Ruth
    Lammer, Jan
    Roberts, Philipp
    Funk, Marion
    Agis, Hermine
    Schmidinger, Gerald
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 242 : 116 - 124